256 related articles for article (PubMed ID: 10906206)
1. Modification of the cytoplasmic domain of influenza virus hemagglutinin affects enlargement of the fusion pore.
Kozerski C; Ponimaskin E; Schroth-Diez B; Schmidt MF; Herrmann A
J Virol; 2000 Aug; 74(16):7529-37. PubMed ID: 10906206
[TBL] [Abstract][Full Text] [Related]
2. Fusion activity of transmembrane and cytoplasmic domain chimeras of the influenza virus glycoprotein hemagglutinin.
Schroth-Diez B; Ponimaskin E; Reverey H; Schmidt MF; Herrmann A
J Virol; 1998 Jan; 72(1):133-41. PubMed ID: 9420208
[TBL] [Abstract][Full Text] [Related]
3. Amino acid sequence requirements of the transmembrane and cytoplasmic domains of influenza virus hemagglutinin for viable membrane fusion.
Melikyan GB; Lin S; Roth MG; Cohen FS
Mol Biol Cell; 1999 Jun; 10(6):1821-36. PubMed ID: 10359599
[TBL] [Abstract][Full Text] [Related]
4. Domain-structure of cytoplasmic border region is main determinant for palmitoylation of influenza virus hemagglutinin (H7).
Ponimaskin E; Schmidt MF
Virology; 1998 Sep; 249(2):325-35. PubMed ID: 9791024
[TBL] [Abstract][Full Text] [Related]
5. The role of the cytoplasmic tail region of influenza virus hemagglutinin in formation and growth of fusion pores.
Melikyan GB; Jin H; Lamb RA; Cohen FS
Virology; 1997 Aug; 235(1):118-28. PubMed ID: 9300043
[TBL] [Abstract][Full Text] [Related]
6. Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion.
Li M; Li ZN; Yao Q; Yang C; Steinhauer DA; Compans RW
J Virol; 2006 Jun; 80(12):6106-14. PubMed ID: 16731949
[TBL] [Abstract][Full Text] [Related]
7. Acylation of the influenza hemagglutinin modulates fusion activity.
Fischer C; Schroth-Diez B; Herrmann A; Garten W; Klenk HD
Virology; 1998 Sep; 248(2):284-94. PubMed ID: 9721237
[TBL] [Abstract][Full Text] [Related]
8. Elongation of the cytoplasmic tail interferes with the fusion activity of influenza virus hemagglutinin.
Ohuchi M; Fischer C; Ohuchi R; Herwig A; Klenk HD
J Virol; 1998 May; 72(5):3554-9. PubMed ID: 9557635
[TBL] [Abstract][Full Text] [Related]
9. The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores.
Markosyan RM; Cohen FS; Melikyan GB
Mol Biol Cell; 2000 Apr; 11(4):1143-52. PubMed ID: 10749920
[TBL] [Abstract][Full Text] [Related]
10. Endocytosis of chimeric influenza virus hemagglutinin proteins that lack a cytoplasmic recognition feature for coated pits.
Lazarovits J; Naim HY; Rodriguez AC; Wang RH; Fire E; Bird C; Henis YI; Roth MG
J Cell Biol; 1996 Jul; 134(2):339-48. PubMed ID: 8707820
[TBL] [Abstract][Full Text] [Related]
11. Fatty acids on the A/USSR/77 influenza virus hemagglutinin facilitate the transition from hemifusion to fusion pore formation.
Sakai T; Ohuchi R; Ohuchi M
J Virol; 2002 May; 76(9):4603-11. PubMed ID: 11932425
[TBL] [Abstract][Full Text] [Related]
12. Meta-stability of the hemifusion intermediate induced by glycosylphosphatidylinositol-anchored influenza hemagglutinin.
Nüssler F; Clague MJ; Herrmann A
Biophys J; 1997 Nov; 73(5):2280-91. PubMed ID: 9370425
[TBL] [Abstract][Full Text] [Related]
13. Palmitoylation Contributes to Membrane Curvature in Influenza A Virus Assembly and Hemagglutinin-Mediated Membrane Fusion.
Chlanda P; Mekhedov E; Waters H; Sodt A; Schwartz C; Nair V; Blank PS; Zimmerberg J
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794042
[TBL] [Abstract][Full Text] [Related]
14. Tight binding of influenza virus hemagglutinin to its receptor interferes with fusion pore dilation.
Ohuchi M; Ohuchi R; Sakai T; Matsumoto A
J Virol; 2002 Dec; 76(24):12405-13. PubMed ID: 12438566
[TBL] [Abstract][Full Text] [Related]
15. Influence of additional acylation site(s) of influenza B virus hemagglutinin on syncytium formation.
Ujike M; Nakajima K; Nobusawa E
Microbiol Immunol; 2005; 49(4):355-9. PubMed ID: 15840961
[TBL] [Abstract][Full Text] [Related]
16. Studies on influenza haemagglutinin fusion peptide mutants generated by reverse genetics.
Cross KJ; Wharton SA; Skehel JJ; Wiley DC; Steinhauer DA
EMBO J; 2001 Aug; 20(16):4432-42. PubMed ID: 11500371
[TBL] [Abstract][Full Text] [Related]
17. Hemifusion activity of a chimeric influenza virus hemagglutinin with a putative fusion peptide from hepatitis B virus.
Berting A; Fischer C; Schaefer S; Garten W; Klenk HD; Gerlich WH
Virus Res; 2000 Jun; 68(1):35-49. PubMed ID: 10930661
[TBL] [Abstract][Full Text] [Related]
18. Dilation of the influenza hemagglutinin fusion pore revealed by the kinetics of individual cell-cell fusion events.
Blumenthal R; Sarkar DP; Durell S; Howard DE; Morris SJ
J Cell Biol; 1996 Oct; 135(1):63-71. PubMed ID: 8858163
[TBL] [Abstract][Full Text] [Related]
19. Influence of acylation sites of influenza B virus hemagglutinin on fusion pore formation and dilation.
Ujike M; Nakajima K; Nobusawa E
J Virol; 2004 Nov; 78(21):11536-43. PubMed ID: 15479794
[TBL] [Abstract][Full Text] [Related]
20. Role of the fusion peptide sequence in initial stages of influenza hemagglutinin-induced cell fusion.
Schoch C; Blumenthal R
J Biol Chem; 1993 May; 268(13):9267-74. PubMed ID: 8387488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
